Ferran Torner1, Josep M Segur2, Rosendo Ullot3, Francisco Soldado3, Pedro Domenech3, Lydia DeSena3, Jorge Knorr3. 1. Department of Orthopaedics, Hospital Sant Joan de Déu, University of Barcelona, Passeig Sant Joan de Déu, 2, Esplugues de Llobregat, 08950, Barcelona, Spain. ftorner@hsjdbcn.org. 2. Department of Orthopaedics, Hospital Clinic, University of Barcelona, Barcelona, Spain. 3. Department of Orthopaedics, Hospital Sant Joan de Déu, University of Barcelona, Passeig Sant Joan de Déu, 2, Esplugues de Llobregat, 08950, Barcelona, Spain.
Abstract
PURPOSE: The non-invasive expandable prosthesis for skeletally immature patients is used after limb salvage surgery following tumor resection. The aim of the study was to assess the effectiveness of this treatment. METHODS: Seven paediatric patients with femoral tumors had resection and limb salvage with an uncemented non-invasive growing prosthesis. Mean age at the time of surgery was 9.8 (range 8-12) years. There were six distal femur osteosarcomas and one proximal femur Ewing sarcoma. Six total knee prosthesis were implanted at the time of primary tumor resection and one bipolar hip prosthesis was a revision from a failed osteoarticular hip allograft. Functional outcomes and emotional acceptance were assessed using the MSTS score. RESULTS: The mean follow-up was 65.3 months (range 29-91) months. Two patients died of pulmonary metastasis and there was no local recurrence. The mean femoral resection was 18 cm (range 17-19) on the knee, and 24 cm on the hip. Mean total expansion was 36.4 mm (range 12.3-63.5). The mean MSTS score after rehabilitation was 26.3 (range 21-29). There was one lengthening device failure, one late infection and one patient who required iliofemoral bypass grafting surgery for a pelvic metastasis. No local recurrence occurred. CONCLUSIONS: The non-invasive expandable prosthesis reduces the final limb-length discrepancy in growing patients with an acceptable function and appears to have an advantage as compared to invasive expandable prostheses which require multiple surgical procedures, but the complications rate is still high.
PURPOSE: The non-invasive expandable prosthesis for skeletally immature patients is used after limb salvage surgery following tumor resection. The aim of the study was to assess the effectiveness of this treatment. METHODS: Seven paediatric patients with femoral tumors had resection and limb salvage with an uncemented non-invasive growing prosthesis. Mean age at the time of surgery was 9.8 (range 8-12) years. There were six distal femur osteosarcomas and one proximal femur Ewing sarcoma. Six total knee prosthesis were implanted at the time of primary tumor resection and one bipolar hip prosthesis was a revision from a failed osteoarticular hip allograft. Functional outcomes and emotional acceptance were assessed using the MSTS score. RESULTS: The mean follow-up was 65.3 months (range 29-91) months. Two patients died of pulmonary metastasis and there was no local recurrence. The mean femoral resection was 18 cm (range 17-19) on the knee, and 24 cm on the hip. Mean total expansion was 36.4 mm (range 12.3-63.5). The mean MSTS score after rehabilitation was 26.3 (range 21-29). There was one lengthening device failure, one late infection and one patient who required iliofemoral bypass grafting surgery for a pelvic metastasis. No local recurrence occurred. CONCLUSIONS: The non-invasive expandable prosthesis reduces the final limb-length discrepancy in growing patients with an acceptable function and appears to have an advantage as compared to invasive expandable prostheses which require multiple surgical procedures, but the complications rate is still high.
Entities:
Keywords:
Bone tumor; Growing prosthesis; Limb salvage; Megaprosthesis
Authors: Kathleen Beebe; Joseph Benevenia; Neil Kaushal; Anthony Uglialoro; Neeraj Patel; Francis Patterson Journal: Orthopedics Date: 2010-06-09 Impact factor: 1.390
Authors: Rodolfo Capanna; Domenico A Campanacci; Nicolas Belot; Giovanni Beltrami; Marco Manfrini; Marco Innocenti; Massimo Ceruso Journal: Orthop Clin North Am Date: 2007-01 Impact factor: 2.472
Authors: Alexandre Arkader; Dan C M Viola; Carol D Morris; Patrick J Boland; John H Healey Journal: Clin Orthop Relat Res Date: 2007-06 Impact factor: 4.176
Authors: Mohan V Belthur; Rob J Grimer; Rajeev Suneja; Simon R Carter; Roger M Tillman Journal: J Pediatr Orthop Date: 2003 Mar-Apr Impact factor: 2.324
Authors: Eric R Henderson; Andrew M Pepper; German A Marulanda; Justin D Millard; G Douglas Letson Journal: Clin Orthop Relat Res Date: 2010-11 Impact factor: 4.176
Authors: Carmine Zoccali; Silvia Careri; Dario Attala; Michela Florio; Giuseppe Maria Milano; Marco Giordano Journal: Children (Basel) Date: 2021-05-25